what you should know about fda project optimus for your oncology drug approval
Published 1 year ago • 2.5K plays • Length 42:27Download video MP4
Download video MP3
Similar videos
-
54:26
what oncology drug developers should expect from the fda’s project optimus
-
59:00
what is fda project optimus and how will it impact oncology drug development?
-
31:44
echalk talk: how oncology drug developers can prepare for fda’s project optimus
-
12:07
the fda’s "project optimus" and oncology drugs
-
14:30
oncology drug development and dose optimization: what are the implications of project optimus?
-
1:05:36
project optimus – fda’s new dose optimization & selection paradigm in oncology drug development
-
57:36
project optimus & pediatric drug development
-
35:08
fda modernization act - what does it mean for pharmaceutical scientists?
-
4:27
do you know how to choose lidar ?
-
1:44:48
intro to fhir
-
37:28
the future of robotics as a service with saman farid of formic
-
11:35
2022 nhpdd day 1, session 2, part 3
-
51:33
fda 101
-
1:00:25
fda’s digital transformation | the future of technology & how to prepare
-
57:06
small molecules, biologics, and vaccines: three uniquely divergent roads to fda cmc approval
-
7:31
fda d.i.s.c.o.: fda approval of larotrectinib for advanced malignancies with ntrk gene fusion
-
2:49
the impacts of the fda's policy update on lab-developed tests
-
1:42
dr. lazarus on the importance of companion diagnostics
-
0:11
5. fda does not approve medical product companies, health care facilities, labs, or manufacturers
-
2:41
what should innovators know about meeting with fda?
-
57:12
drug, diagnostic and device development: from scientific findings to fda approval
-
1:25:04
webinar: fda regulatory strategy and value proposition for better medical product development